Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2007-08-21

Clinical Trial Update: Clinical Trial to Determine the Efficacy of Sculptra™ Dermal Filler for the Correction of Contour Deformities Caused by Lipoatrophy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of Sculptra dermal filler for contour deformities caused by lipoatrophy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sculptra Dermal Filler (poly-L-lactic acid)

Snippet

Sponsor: Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc. | Conditions: Lipodystrophy, Emaciation | Phase 4 | Status: WITHDRAWN